At this year’s event, Lallemand Health Solutions will highlight new research and expanded offerings across women’s health, cognition, immune health, and healthy ageing, supporting brand partners looking to differentiate through robust science, regulatory readiness, and meaningful consumer relevance.
Probiotics for Women’s Health: Targeted Solutions Across Life Stages
Women’s health remains a high growth, innovation-driven category, with increasing demand for evidence-based, life-stage-specific solutions. Lallemand Health Solutions will present a strengthened women’s health portfolio built on clinically documented probiotic strains addressing pregnancy, intimate health, digestive comfort during menstruation, and beyond.
- Prenatis, evaluated in a large clinical trial involving 180 pregnant women, was shown to help reduce diagnosed maternal infections and to support the early establishment of a healthy infant gut microbiome, including in C-section-delivered newborns.
- Lacidofil has demonstrated benefits in supporting microbial balance around C-section delivery, particularly when taken proactively, helping mitigate antibiotic-associated disruptions.
- For intimate health, L. plantarum Rosella, one of the most extensively studied strains in this area, supported by six clinical studies involving over 800 women, has shown its ability to support vaginal microbiota balance for recurrent vulvovaginal candidiasis (rVVC) following oral administration
- Beyond intimate health, B. bifidum Rosell-71 has demonstrated benefits for digestive comfort during menstruation, notably by reducing bloating across menstrual cycles.
Together, this body of clinical evidence illustrates the central role of microbiome-targeted probiotics in supporting women’s health across key life stages and responding to unmet needs in a fast-evolving category.
Mental Health: New Clinical Data on Cognitive Capacities
Lallemand Health Solutions will also unveil a new cognitive health offer supported by a recent clinical study conducted in action video gamers taking Cerebiome. Preliminary results demonstrated measurable improvements in cognitive abilities, including attention-related measurements:
- Decrease in reaction time
- Improvement in processing speed
These findings open new perspectives for cognitive capacities, expanding the company’s science-driven mental health portfolio.
Healthy Ageing: Introducing Cerenity
Healthy ageing represents another major strategic focus at Vitafoods 2026. Lallemand Health Solutions will highlight Cerenity, a flagship probiotic solution designed to support mobility, strength, and quality of life through modulation of the gut–muscle axis.
“Cerenity reflects our commitment to supporting healthy ageing from within, through clinically documented microbiome solutions,” says Camille Binachon, Marketing Group Manager, Healthy Ageing.
In a recent clinical study, Cerenity demonstrated beneficial effects on physical performance and quality of life in aging populations. In addition, the healthy ageing portfolio continues to expand with solutions targeting cardiovascular and cognitive health, providing comprehensive support for ageing well.
Award-Winning Postbiotic Immuse for Immune Health
Immune health will also take center stage, with Immuse, the most documented postbiotics for immune support. Last year, Lallemand Health Solutions announced a strategic partnership with Kirin Holdings Company, Limited to expand global visibility of this clinically supported solution.
“Immuse addresses growing demand for reliable, science-backed immune solutions applicable to daily health, sport, and skin health,” says Romane Maillet, Marketing Group Manager, Postbiotics.
Visit Lallemand Health Solutions at Booth #3G146
Industry partners are invited to meet the Lallemand Health Solutions team at booth #3G146 to explore these innovations in detail, discuss formulation and market opportunities, and experience FizzBiotics by Lallemand, a playful, sparkling sensory experience designed to elevate consumer experience.
